HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fazlul H Sarkar Selected Research

indole-3-carbinol

9/2018A new promising way of maintenance therapy in advanced ovarian cancer: a comparative clinical study.
1/2012Activation of AMP-activated protein kinase by 3,3'-Diindolylmethane (DIM) is associated with human prostate cancer cell death in vitro and in vivo.
6/2010Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research.
11/2009Harnessing the fruits of nature for the development of multi-targeted cancer therapeutics.
11/2009Cellular signaling perturbation by natural products.
8/2009Low concentrations of diindolylmethane, a metabolite of indole-3-carbinol, protect against oxidative stress in a BRCA1-dependent manner.
4/2009Cell cycle-dependent effects of 3,3'-diindolylmethane on proliferation and apoptosis of prostate cancer cells.
11/2006Therapeutic intervention of experimental breast cancer bone metastasis by indole-3-carbinol in SCID-human mouse model.
1/2005Inhibition of nuclear translocation of nuclear factor-{kappa}B contributes to 3,3'-diindolylmethane-induced apoptosis in breast cancer cells.
12/2004Indole-3-carbinol and prostate cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fazlul H Sarkar Research Topics

Disease

277Neoplasms (Cancer)
01/2018 - 01/2002
87Pancreatic Neoplasms (Pancreatic Cancer)
01/2018 - 01/2002
83Prostatic Neoplasms (Prostate Cancer)
04/2019 - 01/2002
54Neoplasm Metastasis (Metastasis)
01/2015 - 01/2002
45Breast Neoplasms (Breast Cancer)
01/2016 - 02/2002
26Carcinogenesis
07/2016 - 01/2002
22Colonic Neoplasms (Colon Cancer)
01/2016 - 05/2003
13Carcinoma (Carcinomatosis)
12/2015 - 04/2003
9Inflammation (Inflammations)
11/2013 - 01/2008
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2013 - 12/2007
9Colorectal Neoplasms (Colorectal Cancer)
04/2013 - 05/2003
8Hypoxia (Hypoxemia)
04/2016 - 06/2007
7Adenocarcinoma
02/2013 - 10/2002
6Ovarian Neoplasms (Ovarian Cancer)
09/2018 - 11/2008
6Fibrosis (Cirrhosis)
11/2013 - 08/2004
5Lung Neoplasms (Lung Cancer)
01/2016 - 11/2011
4Chronic Disease (Chronic Diseases)
07/2011 - 04/2008
4Lymphatic Metastasis
10/2008 - 07/2006
3Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2017 - 12/2011
3Pathologic Processes
12/2013 - 08/2009
3Residual Neoplasm
04/2013 - 04/2011

Drug/Important Bio-Agent (IBA)

61MicroRNAs (MicroRNA)IBA
01/2018 - 04/2008
61NF-kappa B (NF-kB)IBA
09/2017 - 01/2002
48IsoflavonesIBA
11/2013 - 01/2002
45GenisteinIBA
01/2014 - 01/2002
37Biological ProductsIBA
01/2018 - 11/2002
36CurcuminIBA
09/2017 - 11/2004
34Proteins (Proteins, Gene)FDA Link
09/2015 - 06/2002
32Pharmaceutical PreparationsIBA
01/2016 - 04/2003
273,3'-diindolylmethane (diindolylmethane)IBA
01/2016 - 04/2003
24GemcitabineFDA Link
11/2013 - 09/2003
22ErbB Receptors (EGF Receptor)IBA
10/2013 - 05/2003
21Androgen Receptors (Androgen Receptor)IBA
01/2016 - 06/2002
21DNA (Deoxyribonucleic Acid)IBA
12/2015 - 01/2002
20Hormones (Hormone)IBA
05/2012 - 02/2002
17indole-3-carbinolIBA
09/2018 - 02/2002
16Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2013 - 12/2002
15AndrogensIBA
04/2019 - 01/2002
15Cisplatin (Platino)FDA LinkGeneric
01/2018 - 05/2004
14Biomarkers (Surrogate Marker)IBA
01/2015 - 01/2003
13Transcription Factors (Transcription Factor)IBA
09/2013 - 04/2003
11Phosphotransferases (Kinase)IBA
01/2015 - 07/2002
11Matrix Metalloproteinases (MMPs)IBA
01/2015 - 12/2002
11AntioxidantsIBA
01/2015 - 01/2002
11Docetaxel (Taxotere)FDA Link
12/2008 - 03/2004
10Antineoplastic Agents (Antineoplastics)IBA
01/2016 - 10/2005
10Complementary DNA (cDNA)IBA
07/2010 - 12/2002
9CopperIBA
04/2016 - 06/2006
9Reactive Oxygen Species (Oxygen Radicals)IBA
04/2016 - 06/2007
9Oxaliplatin (Eloxatin)FDA LinkGeneric
04/2013 - 07/2009
8LigandsIBA
01/2017 - 06/2002
7Platelet-Derived Growth FactorIBA
01/2016 - 12/2007
7ParaffinIBA
05/2015 - 12/2003
7Erlotinib Hydrochloride (CP 358,774)FDA Link
10/2013 - 12/2005
7Epidermal Growth Factor (EGF)IBA
01/2006 - 07/2002
6Estrogen ReceptorsIBA
07/2015 - 02/2002
6Formaldehyde (Formol)FDA Link
05/2015 - 09/2012
6ResveratrolIBA
03/2014 - 01/2009
6CytokinesIBA
02/2013 - 06/2007
6garcinolIBA
02/2013 - 09/2009
5TensinsIBA
09/2017 - 08/2012
5daidzeinIBA
04/2016 - 03/2007
5RNA (Ribonucleic Acid)IBA
11/2015 - 03/2008
5thymoquinoneIBA
05/2013 - 01/2008
5ZincIBA
04/2012 - 03/2004
5Prostate-Specific Antigen (Semenogelase)IBA
10/2008 - 06/2002
5Estrogens (Estrogen)FDA Link
10/2008 - 01/2002
4PlatinumIBA
09/2018 - 11/2008
4Folic Acid (Vitamin M)FDA LinkGeneric
09/2017 - 10/2012
4Histones (Histone)IBA
01/2017 - 04/2010
4VimentinIBA
07/2015 - 10/2010
4Small Interfering RNA (siRNA)IBA
02/2015 - 03/2006
4Epithelial Cell Adhesion MoleculeIBA
08/2014 - 08/2011
4Tyrosine Kinase InhibitorsIBA
10/2013 - 12/2007
4Fluorouracil (Carac)FDA LinkGeneric
04/2013 - 07/2005
4Oncogene Proteins (Oncogene Protein)IBA
01/2013 - 01/2012
4Cadherins (E-Cadherin)IBA
11/2012 - 10/2010
4EnzymesIBA
07/2011 - 07/2004
4SurvivinIBA
06/2010 - 05/2006
4Cyclooxygenase 2 (Cyclooxygenase-2)IBA
05/2010 - 12/2005
4LycopeneIBA
11/2009 - 11/2002
4Proteasome Endopeptidase Complex (Proteasome)IBA
08/2009 - 02/2007
4Proteasome InhibitorsIBA
08/2009 - 11/2006
4Therapeutic UsesIBA
10/2008 - 03/2004
3Phosphoric Monoester Hydrolases (Phosphatases)IBA
09/2017 - 12/2016
33,4-difluorobenzylidenecurcuminIBA
12/2015 - 08/2015
3Metformin (Glucophage)FDA LinkGeneric
06/2014 - 04/2011
3IonsIBA
03/2014 - 04/2011
3PolyphenolsIBA
03/2014 - 05/2010
3TOR Serine-Threonine KinasesIBA
09/2013 - 01/2012
3Peptides (Polypeptides)IBA
04/2013 - 12/2002
3delta tocotrienolIBA
12/2012 - 10/2011
3S-Phase Kinase-Associated Proteins (Skp1 Protein)IBA
11/2012 - 01/2012

Therapy/Procedure

118Therapeutics
09/2018 - 02/2002
22Radiotherapy
05/2014 - 04/2006
20Chemoprevention
07/2016 - 01/2002
16Drug Therapy (Chemotherapy)
09/2018 - 04/2003
3Immunotherapy
01/2018 - 04/2012
3Precision Medicine
01/2015 - 01/2011
3Oral Administration
02/2013 - 05/2010